Advances in Pharmacoepidemiology and Drug Safety

Editorial note on Advances in Pharmacoepidemiology and Drug Safety

Shufeng Zhou Assoicate Dean, Department of Pharmaceutical Science, University of South Florida, USA

, DOI: 10.35248/2167-1052.20.9.e102

The Advances in Pharmacoepidemiology and Drug Safety, Longdom publication, is an international prominent journal focusing on studies pertaining to rare adverse drug reactions, drug efficacy evaluations, drug interaction quantifications, patterns of drug usage, herbal medicines, randomized control trials, case control studies, cross-sectional studies, case cross over studies and cohort studies. Its is an open access and peer reviewed journal by eminent Editorial Board and the manuscripts are peer-reviewed by potential reviewers according to their research interest.

For the last 9 years, published papers have been under the strong and able leadership of our Editor-in-Chief’s Dr. Richard L Slaughter. Especially, we are thankful to for his continuous support and dedication towards the journal will not lost. We the publication office of Pharmacoepidemiology and Drug Safety including me, we all are very honoured and grateful for his selfless devotion towards the journal.

We provide a rapid turn-around time possible for peer reviewing and publishing the article online and to disseminate the articles freely for research, teaching and reference purposes.

The journal of Advances in Pharmacoepidemiology and Drug Safety also serves as a compendium of knowledge in pharmacoepidemiology and drug safety which can be readily accessed by physicians, surgeons, medical scientists, public health professionals, medical students, clinicians, lab researchers, academicians and industry for keeping themselves updated and also to formulate further research programs.

The Advances in Pharmacoepidemiology and Drug Safety regularly publishes reports covering wide range of topics which include new challenges of over drug use, insufficient use and inappropriate use of drugs; Pharmacoepidemiology; improvements in molecular biology techniques and identification of the genetic determinants of drug effects

Applied Strategies in 2019

We have applied many strategies in 2019, i.e.

• Using contacting through Mobile (Whatsapp) phones

• Sent Call for papers for the eminent in the field

• Approaching the Editors suggested eminent

• Approaching potential reviewers for the Call for papers

• Maintaining the frequency of articles.

Conclusion

I wish to provide some perspective from the cycling research community of Advances in Pharmacoepidemiology and Drug Safety with regard to a recent Editorial note of our Journal.

I solely believe that the quality of the journal is based on the Eminence presence in the Editorial Board as well as Reviewer Board (potential reviewers) who strive to make the papers significantly productive and helpful for the scientific community.

Stay Safe & Healthy…!

Thank you!

With kind regards,

John Wayne,

Associate Managing Editor,

Advances in Pharmacoepidemiology and Drug Safety